Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Fostair

- PMLiVE

NICE backs Europe’s first stem cell therapy

Holoclar is approved for routine use in patients with LSCD

UK flag

Mixed news for pharma on UK’s Accelerated Access Review

New funding will go towards ASHNs, SME’s and the Pathway Transformation Fund to name a few

- PMLiVE

EU and UK pharma leaders appeal directly to Brexit negotiators

EFPIA, ABPI and BIA warn Michel Barnier and David Davies an unorderly withdrawal could hit medicine supplies

- PMLiVE

UK pharma launches legal challenge to NICE plans

Applies for judicial review of budget impact test

- PMLiVE

UK signals desire for close post-Brexit relationship with EU

Health and business ministers outline areas where collaboration may continue

- PMLiVE

GSK starts trial of Nucala to seek alternate indications

Asthma therapy drug to be used to target severe nasal polyposis

- PMLiVE

GSK’s Nucala posts mixed results in COPD

Conflicting late-stage trials throw doubt on its prospects

AstraZeneca AZ

AZ trial adds to pessimism about anti-IL-13 asthma drugs

Firm's IL-13 inhibitor failed to reduce the number of asthma attacks compared to placebo

- PMLiVE

UK pharma apprehensive about post-Brexit investment

ABPI calls for a return of the 'white heat' of innovation to the UK

- PMLiVE

Teva launches asthma social media campaign

Hopes awareness drive will improve inhaler use

ABPI London offices

UK pharma calls on next government to be more ambitious

ABPI wants medicines access to reach levels of other developed nations

ABPI London offices

Nearly half of HCPs refuse to disclose pharma payments

Industry data shows firms spent £363m on working with healthcare professionals

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links